108 related articles for article (PubMed ID: 12690630)
1. [Cardiovascular diseases and oxidative stress].
Takahashi H; Hara K
Rinsho Byori; 2003 Feb; 51(2):133-9. PubMed ID: 12690630
[TBL] [Abstract][Full Text] [Related]
2. The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis.
Mehta JL
Can J Cardiol; 2004 Aug; 20 Suppl B():32B-36B. PubMed ID: 15309203
[TBL] [Abstract][Full Text] [Related]
3. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases.
Aviram M
Free Radic Res; 2000 Nov; 33 Suppl():S85-97. PubMed ID: 11191279
[TBL] [Abstract][Full Text] [Related]
4. Clinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular disease.
Fraley AE; Tsimikas S
Curr Opin Lipidol; 2006 Oct; 17(5):502-9. PubMed ID: 16960498
[TBL] [Abstract][Full Text] [Related]
5. Possible association between circulating vascular endothelial growth factor and oxidative stress markers in hemodialysis patients.
Pawlak K; Pawlak D; Myśliwiec M
Med Sci Monit; 2006 Apr; 12(4):CR181-5. PubMed ID: 16572054
[TBL] [Abstract][Full Text] [Related]
6. Role of oxidative modifications in atherosclerosis.
Stocker R; Keaney JF
Physiol Rev; 2004 Oct; 84(4):1381-478. PubMed ID: 15383655
[TBL] [Abstract][Full Text] [Related]
7. [Oxidative stress related diseases and biopyrrins].
Shioji I
Rinsho Byori; 2005 Feb; 53(2):155-9. PubMed ID: 15796050
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to oxidized low density lipoprotein: epidemiological studies and potential clinical applications in cardiovascular disease.
Gounopoulos P; Merki E; Hansen LF; Choi SH; Tsimikas S
Minerva Cardioangiol; 2007 Dec; 55(6):821-37. PubMed ID: 18091649
[TBL] [Abstract][Full Text] [Related]
9. [Lox-1--an actor in cardiovascular disease?].
Ranheim T; Halvorsen B
Tidsskr Nor Laegeforen; 2006 Mar; 126(6):753-5. PubMed ID: 16541167
[TBL] [Abstract][Full Text] [Related]
10. Urinary excretion of biopyrrins, oxidative metabolites of bilirubin, increases in patients with psychiatric disorders.
Miyaoka T; Yasukawa R; Yasuda H; Shimizu M; Mizuno S; Sukegawa T; Inagaki T; Horiguchi J
Eur Neuropsychopharmacol; 2005 May; 15(3):249-52. PubMed ID: 15820412
[TBL] [Abstract][Full Text] [Related]
11. The expression and down stream effect of lectin like-oxidized low density lipoprotein 1 (LOX-1) in hyperglycemic state.
Rudijanto A
Acta Med Indones; 2007; 39(1):36-43. PubMed ID: 17939209
[TBL] [Abstract][Full Text] [Related]
12. Lectin-like oxidized LDL receptor-1 as extracellular chaperone receptor: its versatile functions and human diseases.
Inoue N; Sawamura T
Methods; 2007 Nov; 43(3):218-22. PubMed ID: 17920518
[TBL] [Abstract][Full Text] [Related]
13. Uric acid and oxidative stress: relative impact on cardiovascular risk?
Strazzullo P; Puig JG
Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):409-14. PubMed ID: 17643880
[TBL] [Abstract][Full Text] [Related]
14. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 correlates with oxidative stress markers in stable coronary artery disease.
Kamezaki F; Yamashita K; Tasaki H; Kume N; Mitsuoka H; Kita T; Adachi T; Otsuji Y
Int J Cardiol; 2009 May; 134(2):285-7. PubMed ID: 18367271
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress in obstructive sleep apnoea.
Svatikova A; Wolk R; Lerman LO; Juncos LA; Greene EL; McConnell JP; Somers VK
Eur Heart J; 2005 Nov; 26(22):2435-9. PubMed ID: 16105851
[TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein cholesterol determines oxidative stress and endothelial dysfunction in saphenous veins from patients with coronary artery disease.
Al-Benna S; Hamilton CA; McClure JD; Rogers PN; Berg GA; Ford I; Delles C; Dominiczak AF
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):218-23. PubMed ID: 16254199
[TBL] [Abstract][Full Text] [Related]
17. Estimation of oxidative stress in cardiovascular diseases.
Olinescu R; Popovici D; Hertoghe J; Hulea S
Rom J Intern Med; 1994; 32(2):129-36. PubMed ID: 7920327
[TBL] [Abstract][Full Text] [Related]
18. [Oxidative stress, atherogenesis and cardiovascular risk factors].
Leborgne L; Mazière JC; Mazière C; Andrejak M
Arch Mal Coeur Vaiss; 2002 Sep; 95(9):805-14. PubMed ID: 12407796
[TBL] [Abstract][Full Text] [Related]
19. Effects of long-term nicorandil administration on endothelial function, inflammation, and oxidative stress in patients without coronary artery disease.
Ishibashi Y; Takahashi N; Tokumaru A; Karino K; Sugamori T; Sakane T; Yoshitomi H; Sato H; Oyake N; Murakami Y; Shimada T
J Cardiovasc Pharmacol; 2008 Mar; 51(3):311-6. PubMed ID: 18356697
[TBL] [Abstract][Full Text] [Related]
20. [Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease].
Galle J
Herz; 2004 Feb; 29(1):4-11. PubMed ID: 14968336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
